Journal Information
Share
Share
Download PDF
More article options
Original article
Open Access
Ceftolozane-tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing healthcare-associated infections in Latin America: report from an antimicrobial surveillance program (2013–2015)
Michael A. Pfallera,b, Dee Shortridgea,
Corresponding author
dee-shortridge@jmilabs.com

Corresponding author.
, Helio S. Sadera, Ana Galesc, Mariana Castanheiraa, Robert K. Flamma
a JMI Laboratories, North Liberty, IA, United States
b University of Iowa, College of Medicine, Iowa City, IA, United States
c Universidade Federal de São Paulo, São Paulo, SP, Brazil

Article

This article is available in English

Ceftolozane-tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing healthcare-associated infections in Latin America: report from an antimicrobial surveillance program (2013–2015)

Michael A. Pfaller, Dee Shortridge, Helio S. Sader, Ana Gales, Mariana Castanheira, Robert K. Flamm
10.1016/j.bjid.2017.06.008
Braz J Infect Dis. 2017;21:627-37
The Brazilian Journal of Infectious Diseases